Literature DB >> 12508955

Cardiovascular risks in obesity.

E C Uchegbu1, P G Kopelman.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12508955     DOI： 10.1007/BF03344056

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  36 in total

1.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

Authors:  M A Austin; M C King; K M Vranizan; R M Krauss
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

2.  American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee.

Authors:  R H Eckel; R M Krauss
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

3.  Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.

Authors:  M Woodward; G D Lowe; A Rumley; H Tunstall-Pedoe; H Philippou; D A Lane; C E Morrison
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

4.  Fatty infiltration: another restrictive cardiomyopathic pattern.

Authors:  J P Dervan; A Ilercil; P B Kane; C Anagnostopoulos
Journal:  Cathet Cardiovasc Diagn       Date:  1991-03

5.  The relation of body fat mass and distribution to markers of chronic inflammation.

Authors:  A Festa; R D'Agostino; K Williams; A J Karter; E J Mayer-Davis; R P Tracy; S M Haffner
Journal:  Int J Obes Relat Metab Disord       Date:  2001-10

6.  Role of the sympathetic nervous system in blood pressure maintenance in obesity.

Authors:  J R Sowers; L A Whitfield; R A Catania; N Stern; M L Tuck; L Dornfeld; M Maxwell
Journal:  J Clin Endocrinol Metab       Date:  1982-06       Impact factor: 5.958

7.  Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

Authors:  J M Chan; E B Rimm; G A Colditz; M J Stampfer; W C Willett
Journal:  Diabetes Care       Date:  1994-09       Impact factor: 19.112

8.  The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study.

Authors:  M S Lauer; K M Anderson; W B Kannel; D Levy
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

9.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

Review 10.  Cardiovascular adaptation to obesity and hypertension.

Authors:  C J Lavie; F H Messerli
Journal:  Chest       Date:  1986-08       Impact factor: 9.410
View more
  3 in total

1.  Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation.

Authors:  Markella V Zanni; Takara L Stanley; Hideo Makimura; Cindy Y Chen; Steven K Grinspoon
Journal:  Clin Endocrinol (Oxf)       Date:  2010-07       Impact factor: 3.478

2.  MicroRNA-196 Regulates HOX Gene Expression in Human Gluteal Adipose Tissue.

Authors:  Adeline Divoux; Hui Xie; Jian-Liang Li; Kalypso Karastergiou; Ranjan J Perera; R Jeffrey Chang; Susan K Fried; Steven R Smith
Journal:  Obesity (Silver Spring)       Date:  2017-06-25       Impact factor: 5.002

Review 3.  Novel molecular aspects of ghrelin and leptin in the control of adipobiology and the cardiovascular system.

Authors:  Amaia Rodríguez
Journal:  Obes Facts       Date:  2014-03-26       Impact factor: 3.942
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.